EVH mission To achieve and maintain the highest level of EU pandemic readiness through the establishment of a consortium enabling research, development and production of safe and effective vaccines and monoclonal antibodies. EVH vision Rapid and equitable access to safe and effective Pandemic vaccines and monoclonal antibodies to the European Union through its innovative and resilient consortium. [...]
EVH is organised around 4 Pillars, each supporting key activities and infrastructures of the vaccine development pipeline: Pillar 1 – Discovery, led by Fondazione Biotecnopolo di Siena (FBS, Italy) Pillar 2 – Pre-clinical Studies, led by Institut Pasteur (IP, France) Pillar 3 – Clinical Studies, led by Vaccinopolis (UA, Belgium) Pillar 4 – Regulation & Manufacturing, led by Deutsches Zentrum f [...]
Develop and implement a pandemic vaccines readiness plan for Europe Develop pandemic vaccine candidates for agreed pathogens up to Phase 2 clinical trials, including through relevant in vitro and in vivo models. Organise and optimise the clinical evaluation of candidate vaccines including in Phases I and II and the appropriate and supportive use of controlled infection facilities to speed up clinica [...]
The project has the scope to provide EU with a self sustainable and independent ability to discover, develop and manufacture vaccines and monoclonal antibodies against infectious diseases of epidemic and pandemic potential. The EVH project contributes to the development of an agreed set of pandemic-prototype vaccines and scalable technologies through a consortium including leading EU organisations directl [...]
© Copyright 2025 The European Vaccine Hub. All rights reserved
Designed and Developed by Pixwork